Sleep-Wake Regulation and Its Impact on Working Memory Performance: The Role of Adenosine by Reichert, Carolin Franziska et al.
biology
Review
Sleep-Wake Regulation and Its Impact on Working
Memory Performance: The Role of Adenosine
Carolin Franziska Reichert 1,2,*, Micheline Maire 1,2, Christina Schmidt 3 and
Christian Cajochen 1,2
1 Centre for Chronobiology, Psychiatric Hospital of the University of Basel, Wilhelm Klein-Strasse 27,
Basel 4012, Switzerland; mi_maire@hotmail.com (M.M.); christian.cajochen@upkbs.ch (C.C.)
2 Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel,
Birmannsgasse 8, Basel 4055, Switzerland
3 Cyclotron Research Centre, University of Liège, Allée du 6 Août n˝8, Liège 4000, Belgium;
christina.schmidt@ulg.ac.be
* Correspondence: carolin.reichert@upkbs.ch; Tel.: +41-61-325-50-57; Fax: +41-0-61-325-55-85
Academic Editor: Chris O'Callaghan
Received: 28 November 2015; Accepted: 19 January 2016; Published: 5 February 2016
Abstract: The sleep-wake cycle is regulated by a fine-tuned interplay between sleep-homeostatic
and circadian mechanisms. Compelling evidence suggests that adenosine plays an important role in
mediating the increase of homeostatic sleep pressure during time spent awake and its decrease during
sleep. Here, we summarize evidence that adenosinergic mechanisms regulate not only the dynamic
of sleep pressure, but are also implicated in the interaction of homeostatic and circadian processes.
We review how this interaction becomes evident at several levels, including electrophysiological
data, neuroimaging studies and behavioral observations. Regarding complex human behavior,
we particularly focus on sleep-wake regulatory influences on working memory performance and
underlying brain activity, with a specific emphasis on the role of adenosine in this interplay. We
conclude that a change in adenosinergic mechanisms, whether exogenous or endogenous, does not
only impact on sleep-homeostatic processes, but also interferes with the circadian timing system.
Keywords: circadian; sleep homeostasis; adenosine; working memory; cognition
1. Introduction
The two-process model of sleep-wake regulation was initially proposed in 1982 by Borbély
and has been continuously refined ever since [1,2]. Overwhelming evidence confirmed that mainly
two processes, a sleep-homeostatic and a circadian process, regulate quantity, quality and timing
of sleep and wakefulness. Furthermore, empirical observations showed that sleep-homeostatic
and circadian mechanisms interact: The influence of the circadian timing system, as mirrored at
a genetic [3], electrophysiological [4], blood-oxygen-level dependent (BOLD) [5] and behavioral
level [6] is dependent on the status of the sleep homeostat. The neuro-pharmacological mechanisms
underlying this interaction are currently investigated.
Here, we focus on the role of adenosine, a neuro-modulator ubiquitously present in widespread
cerebral networks [7,8]. Based on extensive evidence, this nucleoside has been thought to be one of
the so-called sleep-factors [9], i.e., substances which increase during wakefulness and decrease during
time spent asleep, particularly during deep sleep. These sleep-factors (see [9] for overview) are thus
thought to track homeostatic sleep pressure and to mediate its effects ranging from metabolism and
immune functions to highly complex cognitive behaviors. In this review, we summarize evidence that
adenosine is implicated in the sleep pressure-dependent modulation of circadian mechanisms.
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The impact of sleep pressure on working memory (WM) performance and its underlying
cerebral correlates has repeatedly been investigated (see [10] for overview). Studies indicate that
WM functions do not simply decline with rising sleep pressure, but are differentially regulated by
factors interacting with the sleep homeostatic process, such as inter-individual differences (e.g., in
genetic polymorphisms [11–14], age (for overview, see [15])) or time of day ([16–21], but see [22,23]).
After summarizing evidence about circadian and sleep-homeostatic, in particular adenosinergic
mechanisms on electroencephalographic (EEG), hormonal and subjective sleepiness data, we will
specifically review the current knowledge about the regulation of WM performance and the underlying
neuronal mechanisms.
2. Sleep-Wake Regulation: Concepts and Empirical Evidence
2.1. Sleep-Wake Regulation at a Conceptual Level
The timing, duration, and quality of sleep and wakefulness are regulated by the combined action
of two processes [1]. The sleep homeostatic process can be basically described as a rise of sleep pressure
during wakefulness and its dissipation during sleep, as measured by slow electroencephalographic
(EEG) activity [1,24]. The term “homeostasis” refers to the compensatory facilitation of deep,
continuous, and long sleep episodes when sleep is initiated after a long episode of wakefulness [25].
Neuropharmacologically, several substances, so-called sleep factors, have been identified, mediating
the dynamics of sleep homeostatic effects during wakefulness and sleep [9]. The specific function of
sleep homeostatic mechanisms in the brain has been mainly discussed in terms of energy restoration
and cellular defense [9] as well as synaptic plasticity [26].
The second process refers to circadian oscillations (lat. circa = about, dies = day), which
superimpose a nearly 24-h pattern on the sleep-wake cycle: In diurnal species, the circadian system
actively promotes wakefulness during the biological day, while it promotes sleep during the biological
night, i.e., during phases of melatonin secretion by the pineal gland [27,28]. This rhythm is triggered
and adjusted to the external light-dark cycle by light inputs to the brain’s main circadian pacemaker, the
suprachiasmatic nuclei (SCN) of the anterior hypothalamus [29]. Within the SCN, a genetic clockwork
determines the endogenous rhythm by a self-sustaining feedback loop with a duration of nearly
24 h [3]. The synchronization to the external light-dark cycle is mainly based on the ocular perception
and transduction of environmental light information to the SCN [30]. This general mechanism to
synchronize with the rhythm of environmental signals, so-called zeitgebers, is evolutionarily highly
conserved and can be observed in almost all species [31].
Along the 24-h cycle, circadian and sleep homeostatic mechanisms act either in synchrony or
in opposition to each other (Figure 1). When wakefulness of diurnal organisms is scheduled to
occur during daytime and sleep during nighttime (i.e., under so-called entrained conditions), circadian
arousal-promoting mechanisms oppose rising sleep pressure levels during daytime [27]. This opposing
action enables a consolidated episode of wakefulness under accumulating sleep need [28]. With the
onset of melatonin secretion in the late evening hours, the circadian wake-promoting impact breaks
down and the “gate for sleep” opens [32]. Together with high sleep pressure levels, this time can
be considered as an optimal window for sleep initiation. Towards the end of a night-sleep episode,
when sleep pressure has mostly dissipated, sleep is presumably maintained due to active circadian
sleep-promoting mechanisms [27].
Overall, both circadian and sleep homeostatic mechanisms contribute to consolidated wake and
sleep bouts under entrained conditions. Consequently, disruption of the interplay of both processes, for
instance, due to shift work or travelling across time zones, reduces sleep and wake quality. At several
behavioral and physiological levels, the impact of circadian modulations on sleep and wakefulness
crucially depends on sleep pressure levels [6]. When sleep pressure is at low levels, the circadian
arousal peak in the late evening hours is particularly pronounced [16,21], while typical circadian
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nighttime troughs in cognitive performance have been shown to be enhanced under high sleep
pressure [16,17,21].
2.2. Investigating Circadian and Sleep Homeostatic Mechanisms
Several laboratory protocols have been developed to investigate the influence of circadian and
sleep homeostatic mechanisms on human behavior and physiology. The most sophisticated design
is the so-called forced desynchrony protocol. In such a study, participants are separated from the
natural environment for several weeks and live according to a specific sleep-wake cycle. This artificial
sleep-wake cycle corresponds to the usual 1:2 ratio of sleep and wakefulness, but is considerably
longer or shorter than the regular 24-h cycle (e.g., [16,17]). As the circadian system is not able to
keep track to the imposed environmental light-dark cycle, it starts to follow its own rhythm and
begins to free-run. Furthermore, sleep and wakefulness occur systematically at differential times of the
biological day or night and are desynchronized from the endogenous circadian rhythm. The influence
of differential sleep pressure levels can thus be assessed at virtually all circadian phases, or, conversely,
circadian influences can be measured under differential sleep pressure conditions. Consequently, a
forced desynchrony protocol allows one to investigate the interaction between circadian and sleep
homeostatic processes and to quantify their separate contribution to output parameters, such as sleep
and waking electroencephalography (EEG) or cognitive performance.
A less time-consuming way to study the impact of differential sleep pressure levels at the same
circadian phase is the implementation of a so-called constant routine protocol with a duration of
more than 24 h. This design requires participants to stay continuously awake while the influence
of potential zeitgebers such as light, body posture, meal intake, or sleep and wakefulness is kept
constant [33]. The protocol was originally developed to investigate unmasked circadian rhythms.
When extending wakefulness to more than 24 h, it also enables one to assess dependent variables at
the same circadian phase under differential sleep pressure levels. However, it has to be taken into
account that sleep deprivation (SD) per se might delay circadian phase position [34]. Additionally,
a separation of circadian and sleep homeostatic influences is not possible, as a certain level of sleep
pressure does not systematically occur at all circadian phases.
To control for this confound, multiple-nap protocols (NP) have been developed, in which regularly
scheduled naps serve to keep homeostatic sleep pressure at a rather low level throughout the 24-h cycle.
This allows the studying of the circadian course of several waking functions without the confounding
rise in sleep pressure (e.g., [22,23,35–37]). Importantly, the regularly scheduled sleep episodes further
enable one to assess circadian variations in differential sleep features [32,38,39]. A disadvantage is that
the fragmentation of sleep prevents ultradian processes requiring long and continuous sleep-episodes.
Nonetheless, a combination of a constant routine and an NP appears to be a useful alternative to the
much more laborious forced desynchrony protocol.
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Figure 1. Illustration of human sleep-wake regulation by circadian and homeostatic mechanisms under
entrained conditions. Under entrained conditions wakefulness is scheduled to daytime, and sleep to
the biological night. The homeostatic sleep nee (blue) increases during wakefulness and declines
during sleep. Circadian oscillations (yellow) promote wakefulness during the day and sleep during
the night, and are relatively independent of prior sleep-wake history. Figure and legend adapted from
a previous publication [40]. Reproduced with permission.
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2.3. Circadian and Sleep Homeostatic Regulation of Sleep and Waking Functions
2.3.1. Circadian and Homeostatic Regulation of Sleep Features
Various sleep features are affected by circadian and sleep homeostatic
mechanisms (e.g., [16,27,38,39,41,42]). Slow-wave sleep (SWS) duration [16] and NREM (non
rapid-eye movement) sleep spectral power in the range of 0.7–4 Hz [42] mirror the dynamics of
homeostatic sleep pressure [2], particularly in frontal areas [43]. These features are more pronounced if
more time is spent awake before initiation of sleep, and decrease over the course of a sleep episode.
Additionally, NREM EEG power density in the range of 12–16 Hz (sigma activity) shows a sleep
homeostatic pattern as well, but is also strongly modulated by circadian phase [42].
On the other hand, sleep latency (Figure 2) and sleep efficiency for example follow a clear-cut
circadian pattern. They mirror the course of circadian arousal promotion, with difficulties to initiate
and maintain sleep during daytime, specifically at the end of the biological day [27,39]. During the
late evening hours at the end of a day, circadian wake-promotion reaches peak-levels (see Figure 1).
Accordingly, this time window has been labelled as the “wake-maintenance zone” [44]. Similarly, peak
levels of active circadian sleep promotion in the early morning (see Figure 1) have been proposed to be
mirrored in prominent circadian peaks of REM (rapid-eye movement) sleep duration [41,45].
Generally, it should be noted that a strong circadian or homeostatic control of a specific sleep
feature might not be understood as exclusive, but rather as a predominance of one of the two
sleep-wake regulatory mechanisms under specific conditions. For instance, sleep latency is shortened
under high sleep pressure [46,47], and sleep efficiency decreases according to time spent asleep [16].
Furthermore, REM sleep duration is modulated by time spent asleep, in a circadian phase-dependent
manner [41]. Finally, the core marker of NREM sleep homeostasis, slow-wave activity (SWA), exhibits
a “small but significant” [41] circadian variation [48]. Taken together, these observations strengthen
the assumption of an inherent connection between circadian and sleep homeostatic mechanisms in the
regulation of sleep features.
Figure 2. Time course of sleep latency over the 24-h cycle in a 40-h nap protocol. Sleep latency to sleep
stage 1, assessed during regular naps of 80 min (NP, see [49] for details), shows a striking circadian
pattern. Longest durations occur in the evening hours shortly before habitual bedtime and mirror
highest levels of circadian wake promotion at the end of the biological day [27]. Shortest durations
were measured during the biological night, which is illustrated by the blue dotted curve of melatonin
secretion. Melatonin was analyzed in saliva samples collected in the same study [12,49] and modelled
according to algorithms published in [50].
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2.3.2. Circadian and Homeostatic Regulation of Waking Functions
Circadian and homeostatic profiles have repeatedly been observed in several waking functions,
ranging from waking EEG, to behavioral performance, and in both subjective and objective measures
of sleepiness. For instance, alpha activity (8–12 Hz) decreases [51], and performance deteriorates, with
time spent awake [16–18]. Similarly, frontal EEG delta activity (1–4.5 Hz) increases [51], and subjective
sleepiness rises continuously, if more time is spent awake [16].
Most of these measures are as well affected by circadian phase. Generally, the impact of
circadian phase has been shown as nighttime trough in waking EEG alpha activity (8–12 Hz; [51])
and cognitive performance [16–18]. Additionally, sleepiness is enhanced during nighttime, both
subjectively (Figure 3; [16]) and objectively, as measured by electrooculographic slow-rolling eye
movements [52].
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Figure 3. Circadian and homeostatic influences on subjective sleepiness, WM performance, and waking
EEG. Values assessed during a low sleep pressure condition (NP) are depicted on the left panel, and
mirror circadian influences under rather low sleep pressure conditions. On the right side, the impact of
rising sleep pressure during night- and daytime is illustrated, as these values were assessed during a
SD of 40 h. The grey bars indicate nighttime. Subjective sleepiness was assessed by a questionnaire
(Karolinska Sleepiness Scale [53]), WM performance by an n-back task (depicted is the percentage of
hits). The waking EEG was analyzed over three frontal derivations (F3, F4, FZ). Please see [12,49] for
further information on data assessments and study protocol.
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Finally, both circadian and homeostatic mechanisms act in a combined manner on waking quality.
The typical interaction of these processes can be nicely observed during SD (see Figure 3). During the
first day, that is, under usual sleep pressure levels, frontal low EEG activity, sleepiness, well-being
and performance are relatively stable. However, once the biological night is reached, frontal low EEG
activity and sleepiness steeply increase, while performance and well-being deteriorate concomitantly.
Intriguingly, once the biological day is reached (i.e., after around 31 h of continuous wakefulness), the
values stabilize or even approach baseline levels, even though wakefulness is further extended (see
also [22,35–37,52]). This daytime stabilization under high sleep pressure is most likely due to circadian
arousal-promoting mechanisms that oppose high sleep pressure levels during daytime [54].
While it is tempting to assume that all these measures are closely correlated, underlining evidence
is mixed so far. Most studies focused on the relationship between subjective and objective sleepiness,
assessed under rising and high sleep pressure (previously reviewed for the Karolinska Sleepiness
Scale [55]). However, under high sleep pressure, people react differently (but intra-individually stable)
according to the domain of measurement (e.g., domains such as self-evaluation of sleepiness, cognitive
processing capability or sustained attention performance [56]). Thus, given the same person, subjective
and objective sleepiness might not be affected to the same extent by high sleep pressure. This might
hamper a striking correlation between differential measures assessed under such conditions.
2.4. Neuronal Underpinnings of Sleep and Wakefulness and the Role of Adenosine
2.4.1. Adenosinergic Regulation of Sleep Homeostasis
Sleep homeostatic mechanisms in the brain have been associated with the increase and decrease
of substances, so-called sleep-factors, in widespread cerebral networks (e.g., adenosine, nitric oxide,
tumor necrosis factor α, brain-derived neurotrophic factor or interleukin 1 [9]). Here, the focus will
be on evidence underlining the role of adenosine and its metabolism. Its important role in human
sleep-wake regulation is underlined by the world-wide common use of the non-selective adenosine
antagonist caffeine [7].
A Role of Adenosine in Sleep Homeostasis—Implicated Brain Regions
The nucleoside adenosine is intra- and extracellularly ubiquitous in the central nervous system.
It acts on sleep-wake regulation mainly via its widely distributed inhibitory A1 receptors [7,8]. In
animals, adenosine levels increase in several brain areas during extended wakefulness, and decrease
during recovery sleep from SD. Moreover, adenosine inhibits arousal and induces sleep, modulated by
receptors in the basal forebrain [57–60]. Evidence suggests further inhibitory influences on other
structures crucially involved in arousal promotion (for an overview, see Figure 4a) such as the
tuberomamillary nuclei (TMN), or orexin containing neurons in the lateral hypothalamus (LH; [8]).
Conversely, adenosine has an excitatory influence via A2A receptors in the sleep-promoting neurons
in the ventrolateral preoptic area (VLPO) of the hypothalamus (Figure 4b; [61]). In sum, adenosine
appears to be a powerful modulator of arousal-promoting brain structures.
Why Does Adenosine Increase with Time Spent Awake? Contributions of Its Metabolization
Adenosine is the end-product of the hydrolysis of adenosine triphosphate, the so-called “energy
currency” [8]. Consequently, it has been related to the energy consumption of a cell [8]. However, an
increase and decrease of adenosine, linked to sleep homeostasis, is not necessarily or exclusively due
to increased or decreased energy demands. It can also strongly depend on adenosine metabolization
and transport. Extracellular clearance of adenosine is mostly regulated via nucleoside transporters [62]
or ecto-adenosine deaminase [7]. Intracellularly, adenosine is converted by adenosine kinase, or
metabolized by adenosine deaminase (ADA) to inosine [7]. The ADA-dependent degradation plays a
presumably crucial role under conditions of high adenosine concentrations [62].
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There is evidence that adenosine degradation plays a role in sleep wake-regulation. For instance,
the activity of several adenosine metabolizing enzymes shows a diurnal rhythm [63]. During the active
phase, ADA activity has been observed to peak in the VLPO, while exhibiting troughs in the basal
forebrain. Additionally, pharmacological inhibition of ADA leads to a rise in extracellular adenosine
and prolongs NREM sleep [64–66]. Moreover, Franken et al. demonstrated that a region which encodes
ADA in mice is associated with the rate of NREM sleep need accumulation [67]. However, ADA
activity remained unchanged after SD in several sleep-wake regulatory brain areas, such as the LC,
TMN, VLPO and basal forebrain [63].
In humans, the single nucleotide polymorphism rs73598374 has been linked to differences in
enzymatic activity in blood cells [68,69]. Compared to G/G-allele carriers, the catalytic ADA activity is
reduced in G/A-allele carriers by around 20%. Enzymatic activity in A/A-allele carriers is unknown
so far. Longer SWS and higher EEG power in the slow-wave range during NREM sleep was observed
in G/A- compared to G/G-allele carriers in baseline [70,71] and recovery nights from SD [71]. An
epidemiological study revealed higher sleep efficiency, but not a longer duration of SWS, in G/A-allele
carriers [72]. Yet, a higher EEG power in heterozygous individuals in the delta range during SWS was
confirmed, which was, however, limited to occipital derivations [73]. Furthermore, higher subjective
sleepiness in G/A- compared to G/G-allele carriers over 40 h [12,71] underlines a potential higher
sleep pressure in heterozygous individuals. However, the results regarding genotype-dependent
differences in vigilance performance is less consistent [12,71,74], potentially due to small sample sizes,
and differential statistical methods.
Overall, the literature suggests that the adenosinergic system, including built up, degradation,
transport and receptors (an overview about receptors is available [75]), strongly contributes to changes
in physiology and behavior according to time spent awake. The existing evidence indicating an
interaction of adenosinergic with circadian mechanisms will be summarized next, after a brief
description of the pathways and neurotransmitters involved in circadian sleep-wake promotion.
2.4.2. Pathways of Circadian Arousal Promotion
The SCN has a central role in the regulation of circadian rhythmicity. It has often been labelled as
the director of an orchestra of circadian rhythms ticking in most cells of the body (e.g., [76,77]). SCN
lesions in animals [29] and humans [78,79] indicate that the SCN is not only crucially involved in the
timing of sleep and wakefulness, but also in its consolidation (reviewed in [80]). However, it has to be
noted that all lesions might have involved a destruction of SCN adjacent areas [29,80].
The SCN receives light-dark information via the retinohypothalamic tract [30]. Downstream from
the SCN, circadian arousal promotion during daytime is most likely mediated via several interfaces,
including the dorsomedial hypothalamus (DMH) and orexinergic neurons in the LH (Figure 4b). The
latter have been shown to be crucially important to consolidate wakefulness [81]. They target the
noradrenergic neurons of the locus coeruleus (LC; [29]). Together with other projections (Figure 4a),
the LC provides excitatory input to a widespread cortical network (Figure 4a; e.g., [81–87]).
During the biological night, circadian arousal promotion is reduced. The circadian phase
information is, again via several interfaces (Figure 4b), transduced to arousal-inhibiting brain
structures [29]. Particularly important in arousal inhibition are sleep-active neurons of the VLPO. They
inhibit via GABA-ergic input not only orexinergic LH neurons, but also nearly all brainstem structures,
mediating arousal, such as the TMN, raphe nuclei, pedunculopontine and laterodorsal tegmental
nuclei and the LC [81]. In turn, the activity of the VLPO is inhibited by the ascending monoaminergic
projections, for instance, from the LC, and by GABA-ergic input from the DMH. This forms a reciprocal
system between arousal promoting and reducing brain areas [29,88].
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(A) The asce ding arousal system. One of the main pathways (red) activating t e c rtex arises fro
neurons in the monoaminergic cell groups, including the locus coeruleus (LC) containing noradrenaline
(NA), the dorsal and median raphe nuclei containing serotonin (5-HT), the A10 cell group containing
dopamine (DA), and the tuberomammillary nucleus (TMN) containing histamine (His). This pathway
receives contributions from peptidergic neurons in the lateral hypothalamus (LHA) containing orexin
(ORX) or melanin-concentrating hormone (MCH), and from basal forebrain (BF) neurons that contain
γ-aminobutyric acid (GABA) or acetylcholine (Ach). The red pathway activates the cerebral cortex to
facilitate the processing of inputs from the thalamus. Orange lines represent input to the thalamus
originating from cholinergic (ACh) cell groups in the upper pons, the pedunculopontine (PPT)
and laterodorsal tegmental nuclei (LDT). Figure and legend modified from a previous work [81].
(B) Hypothalamic and adenosinergic arousal modulation. The SCN innervates by GABA-ergic neurons
the ventral supraventricular zone. The latter projects to the dorsomedial hypothalamus (DMH), in
turn providing glutamatergic input to the orexin-containing neurons in the lateral hypothalamus (LH).
These finally target the locus coeruleus (LC), a major player in the ascending arousal system [87]. The
ascending arousal system is inhibited by GABA-ergic input of the ventrolateral and median preoptic
area (VLPO and MnPO), and in part by adenosine. Adenosine acts inhibitory (blue lines) via A1 or
disinhibitory (green lines) via A2A receptors on several structures within this network. Striped lines
show neural projections of which implicated neurotransmitters are currently unknown.
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2.5. Interactions of Circadian and Sleep Homeostatic Mechanisms
2.5.1. The Genetic Clockwork and Sleep Homeostasis
Evidence for an interaction between homeostatic and circadian processes has been reported within
the genetic clockwork. In simplified terms, this self-sustained circadian feedback loop consists of
several positive and a negative components [3]. The positive components include the coupling of the
transcription factors CLOCK and BMAL1, or NPAS2 and BMAL1, which drive the transcription
of Period (Per1, Per2) and Cryptochrome (Cry1, Cry2) genes. After translation, PER-CRY protein
complexes translocate back to the nucleus to inhibit their own transcription via inhibition of the
complex CLOCK/BMAL1 and NPAS2/BMAL1 (negative component of the feedback loop). Through
posttranslational protein modifications, this inhibition is removed and a new cycle can begin [3].
Furthermore, the network comprises a range of additional feedback loops between core genes,
interactions with several modulators during the processes of transcription and translocation, and also
posttranscriptional and posttranslational modifications [3,89].
So far, it is not fully understood, how sleep homeostatic changes impact on the circadian feedback
loop. Based on knock-out studies, we know that a lack of Bmal [90], Npas2 [91], Per1 and Per2 [92], as
well as Cry1 and Cry2 [93,94] is associated with changes in delta power during recovery sleep from SD.
Furthermore, messenger ribonucleic acid (mRNA) levels of clock genes, such as Per2 or dbp (D-site
binding protein), in the cerebral cortex and other tissues are altered after SD [95]. Interestingly, in
non-sleep deprived animals as well, Per2 expression varies in the forebrain according to EEG delta
power, while expression in the SCN appears to be independent of prior sleep-wake history [96–98].
Similarly, there is first evidence that adenosine might exert an influence on the circadian clockwork.
It has been shown that A2A receptor antagonism and knock-out of an equilibrative adenosine
transporter (equilibrative nucleoside transporter 1 [ENT1]) is linked to blunted Per2 expression in the
striatum, but not in the SCN [99]. Yet, to our knowledge, a direct link between the sleep-homeostatic
regulation of adenosine (i.e., its regulation according to time spent awake) and the genetic circadian
machinery, has not yet been explored. Franken, in a recent review, suggested that sleep homeostatic
mechanisms might affect Per2 expression via corticosterone-bound glucocorticoid-receptors, changes
in brain temperature, metabolism, cytokine levels, altered DNA binding of NPAS2 and BMAL1, or the
redox state [3]. Interestingly, the redox state has been associated with the excitability of SCN neurons
through modulation of several potassium (K+) channels [100].
The circadian changes in membrane excitability and neuronal firing patterns of the SCN depend
on the interplay of a number of ionic factors, such as K+ and Ca2+ currents [101]. They translate the
time signal from the molecular clock into electrophysiological circadian fluctuations, characterized by
a higher frequency and a higher input resistance during the subjective day compared to the subjective
night [102]. How these fluctuations change in the SCN according to sleep pressure will be summarized
in the next section. Furthermore, we will briefly describe other brain regions potentially implicated in
the interaction of the adenosinergic modulation of sleep pressure and circadian mechanisms.
2.5.2. Brain Regions and Substances Mediating the Interaction
In addition to research at the molecular level, electro-physiological studies underline an interaction
between circadian and sleep homeostatic mechanisms amongst others directly in the SCN. Evidence
indicates that firing rates of SCN-neurons are reduced during NREM as compared to REM sleep [103].
Additionally, SCN-activity correlates negatively with sleep pressure [103] and the amplitude of SCN
activity is reduced after SD [4]. In humans, a differential modulation of the SCN according to sleep
pressure is underlined by BOLD activity assessed by functional magnetic resonance imaging (fMRI). In
line with the results derived from animal studies, BOLD activity in a hypothalamic region, putatively
encompassing the SCN, was negatively associated with SWA [5].
Furthermore, SD studies, challenging sleep homeostatic mechanisms, indicate a role of adenosine
in circadian amplitude and timing. A sleep-loss induced reduction of the SCN response to
Biology 2016, 5, 11 10 of 25
light [104,105] could be reinstated by treatment with the adenosine antagonist caffeine [105]. Thus,
it has been suggested that adenosinergic A1 receptors might be involved in a sleep homeostatic
modulation of the activity of the main circadian pacemaker [105]. So far, how this modulation is
influenced by circadian and light-dependent variations of adenosine in the retina [106,107], and its
relation to adenosinergic neurotransmission in the retinohypothalamic tract [108], has yet to be studied.
In mice [105] and human cells [109], caffeine treatment lengthened the circadian period under
normal waking conditions. In humans, an interaction of the adenosinergic with the circadian timing
system is indicated by a melatonin suppression [110] and a phase delay in response to acute caffeine
administration [109], and is further underlined by our observation of an ADA-genotype dependent
shift in the rise of melatonin [12]. Together with evidence from the animal domain [105,111–113],
these findings suggest adenosinergic mechanisms underlying a circadian phase shift in response to
heightened sleep pressure levels due to partial [13,114] as well as total SD [34].
An integration of circadian and sleep homeostatic inputs is also reasonable in the orexin-containing
LH [115]. Orexin-levels show a circadian rhythm, but are also influenced by sleep homeostatic
mechanisms [116]. The impact of sleep pressure might be regulated by adenosinergic A1 receptors in
the LH. Adenosine inhibits orexinergic LH activity [117,118], which stabilizes the state of wakefulness
and prevents sudden transitions to sleep [81,119]. In humans, such a promotion of wakefulness is
particularly important in the evening hours [27], when sleep pressure is at high levels. During this
time window, we observed that the ADA-polymorphism was associated with systematic differences in
wake-promoting strength [49], as indicated by a lower sleep efficiency [27].
Finally, given the widespread projections of the ascending arousal system, indirectly connected to
the SCN (see Figure 4), and the distribution of adenosinergic receptors all over the brain, the integration
of circadian and homeostatic signals is reasonable in various brain regions at the single neuronal level.
It has been shown in rats that the density of adenosinergic A1 receptors in the basal forebrain is
upregulated in response to SD [120]. Similarly, in humans, A1 receptor binding is increased after SD in
several cortical and subcortical regions [121]. Interestingly, the binding potential of these receptors
has been proposed to show a circadian pattern in the cerebral cortex in animals [122]; however, this
finding needs replication under constant lighting conditions.
Overall, the evidence strongly supports an interaction between sleep homeostatic and circadian
mechanisms based on complex and widely distributed neuronal mechanisms. While we focused
here on evidence regarding adenosinergic mechanisms, it should be noted that research has already
identified a range of other sleep-factors (for overview, see [9]). In all likelihood, these not only are
implicated in the increase and decrease of homeostatic sleep pressure, but also contribute to the mutual
influence of sleep homeostatic and circadian processes.
3. Working Memory
As mentioned in Section 2.3.2, sleep-wake regulation crucially impacts cognitive performance.
Circadian and sleep homeostatic variations have repeatedly been reported for several cognitive
domains (see [123] for overview). The interaction of sleep-wake-regulatory mechanisms can be
nicely observed during total SD: Over the course of a normal 16 h waking day, performance stays at
rather stable levels, but steeply decreases once the biological night is reached. During the following
day, cognitive performance stabilizes at a certain level or even improves again, in spite of rising
sleep pressure levels during constant wakefulness (see Figure 3). This stabilization or recovery of
performance during the day after a night of sleep loss is most likely due to circadian wake-promoting
factors opposing high sleep pressure [54].
So far, research has focused mainly on the impact of SD on cognitive performance, whereas pure
circadian variations, independent of sleep pressure, have been less extensively studied. Sleep pressure
has been shown to affect several cognitive domains ranging from basic attentional processes, such as
vigilance, to higher-order cognitive functions, such as working memory or decision-making [123]. The
latter processes have been proposed to be particularly vulnerable to SD because of their dependence
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on the prefrontal cortex (PFC) [124]. The hypothesis was based on EEG ([125], and see also [43,51] for
further evidence) and early neuroimaging studies [126,127], underlining an influence of homeostatic
sleep pressure, particularly in frontal brain areas. In the following, we focus on evidence about
sleep-homeostatic influences on working memory (WM), a complex cognitive process relying on the
PFC’s integrity [128]. After a brief definition of WM and its neuroanatomical basis, we will discuss a
potential role of adenosine in mediating the influence of sleep pressure and finally consider the current
evidence of circadian modulation of WM and its modulation by sleep pressure.
3.1. Working Memory at a Conceptual Level
The main process characterizing WM performance is generally considered as the successful
manipulation of information in a kind of short-term storage. Importantly, WM is distinct from
short-term memory in that it not only refers to a brief storage of information, but also to its
manipulation. Similarly, in animal research, WM is understood as “... a representation of an object,
stimulus, or spatial location that is typically used within a testing session, but not between sessions,
to guide behavior” [129]. Irrespective of a limited storage capacity to a specific “magical” number
of items [130,131], WM performance can be trained successfully by practicing executive aspects of
WM [132–134]. Executive aspects refer to processes apart from storage, for instance, monitoring and
updating of information, inhibition of prepotent responses and mental set shifting (e.g., [135,136]).
The currently best-known conceptualization of WM was originally published by Baddeley
and Hitch first in 1974 [137], and has been continuously refined ever since. According to this
multicomponent theory, the WM system is comprised of several modules [138]: At least two
capacity-limited storage modules, termed phonological loop and visual-spatial sketchpad, are assumed
to store information in a modality specific manner over short terms. These storage modules are linked
to an executive control system. The central executive regulates the manipulation of information within
the storage modules. It is assumed that it controls the focus and the division of attention, and guides
decision-making and switching between tasks. Thus, it is central for processes commonly labeled as
executive functions [138].
Mirroring the diversity of WM processes, there is a wide range of tasks assessing WM functions.
For instance, the WM span tasks are classically used to measure capacity limits of WM (see [139] for a
detailed discussion on reliability and validity). Serial addition tasks serve to assess speed of processing
and updating performance in the short-term storage [140]. Updating information in the short-term
storage, and particularly underlying cerebral correlates, were often deduced by performance in the
n-back task (see [141] for discussion). Furthermore, there are specific tasks focusing on executive
aspects of WM, such as the stroop task or the go/no-go paradigm to assess inhibition capability
(e.g., [142]). Generally, the use of a particular task depends on its validity, reliability, and feasibility
to implement it in a specific setting, such as MRI or conditions of repeated measurements in FD, SD
and NP studies. In animal research, WM performance is often assessed by so-called delay response
paradigms in primates [143], and the Morris water maze [144] or radial arm maze [145] in rodents.
3.2. Neuronal Underpinnings
3.2.1. Brain Activity Patterns
As reviewed extensively by others [136,146–152], brain activity during a WM task typically
involves widespread networks, ranging from prefrontal areas to parietal regions as well as the occipital
lobe. The temporal patterns of the activity distributions appear to fit well to the conceptual models
of WM: Broadly speaking, prefrontal areas, reminiscent of the central executive, control activity in
sensory regions, representing modality specific storage modules [150].
Generally, persistent activity in lateral prefrontal neurons mirrors top-down control of those
regions, which maintain sensory information. The lateral PFC presumably exerts its top-down control
by both active promotion of relevant information and active suppression of irrelevant information [150].
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It has been suggested that the ventrolateral part of the PFC mediates a controlled access to memory
contents and their maintenance [148], while the dorsolateral region appears to be more implicated in
the organization of WM contents into higher-order units of information, so-called chunks [146].
To regulate interference reduction, the pre-supplemental motor area appears to be particularly
important [152]. This area has also been proposed to play a role in the capacity limits of WM, and linked
to the limits in selective attention [153]. A further limiting factor for capacity is activity in more posterior
parietal areas, which are crucially involved in formation and maintenance of information [150,153].
Finally, subcortical areas, such as the striatum or cerebellum are involved in successful WM
performance, for instance, in the suppression of irrelevant information [150] or maintenance of
information and guiding attention [149]. Furthermore, the maintenance of information, particularly in
spatial and relational tasks, has repeatedly been linked to the hippocampus and related brain areas in
the medial temporal lobe [154,155].
3.2.2. Neurotransmitters and Neuromodulators
Numerous neurotransmitters are involved in the regulation of WM performance. Aside from
evidence underlining a role of acetylcholine, norephinephrine or serotonin in the PFC [156], the
presumably largest body of research targets the role of dopamine in the PFC [157,158]. The effects of
dopamine are mirrored in an inverted u-shaped function, such that a deregulation in any direction
has a detrimental impact on performance [159]. In humans, strong evidence for a dopaminergic
modulation of WM arises from impairments of WM functions following pathophysiological changes
in the dopaminergic system (for instance, in schizophrenia [160]).
Intriguingly, the adenosinergic system also plays a role in WM performance modulation under
conditions of normal sleep-wake cycles. As adenosine receptors are expressed in brain areas,
characterized by dopaminergic innervation (e.g., in the cortico-striatal pathways), they are optimally
suited to provide a basis for the interaction between these neurotransmitter systems [161]. Numerous
studies have shown an antagonistic interaction particularly of A2A and dopamine D2 receptors in the
striatum, and there is also evidence for a similar pattern between A1 and dopamine D1 receptors [161].
In rodents, WM performance was enhanced after acute injection of an A1 receptor agonist into the
hippocampus [162,163]. Similarly, overexpression of adenosine kinase, an enzyme implicated in
clearance of adenosine, was linked to a decrease in WM performance [164,165]. Implants of adenosine
releasing cells, located proximal to the hippocampus, restored these WM deficits [164]. However,
while these studies indicate a beneficial effect of adenosine availability on WM performance, there is
also evidence pointing in the opposite direction. For instance, injection of an A2A receptor antagonist
is linked to improvements in WM performance [166]. In line with this result, WM performance
was reduced in rats overexpressing A2A receptors in the cortex, hippocampus and cerebellum [167].
Knock-out of a gene encoding ecto-51-nucleotidase, an enzyme converting adenosine monophosphate
into adenosine, was associated with increased WM performance [166,168]. Furthermore, A2A receptor
knock-out in the entire brain [169], and in particular in the striatum [170], has been linked to
enhancements in WM performance.
Differences between the mentioned studies in the target receptors and their different distribution
throughout the brain (see Section 2.4.1) might account for conflicting results, together with divergences
in the WM tasks used. Moreover, in the light of a detrimental influence of both artificial enhancement
and reduction of the adenosinergic tone, Singer et al. suggested that a “physiological adenosine
concentration” appears to be optimal to maintain a stable neural network underlying WM, including
glutamatergic and dopaminergic networks [171].
In humans, a reduction of the adenosinergic tone appears beneficial for performance under
pathophysiological conditions [172]. However, in healthy adults, performance did not significantly
change after an administration of the adenosine antagonist caffeine, even though differences in
underlying brain activity patterns were observed [173–175]. Notably, the latter studies were conducted
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under normal waking conditions. As summarized below, performance is indeed affected by prolonged
wakefulness, an effect potentially modulated by adenosinergic mechanisms.
3.3. Impact of Sleep Loss
As summarized by Lim and Dinges (2010) in a meta-analysis, WM performance is robustly
affected by sleep loss [176]. However, it is still a matter of debate in which of the various processes
constituting WM performance these decreases specifically occur [177]. According to the so-called
vigilance hypothesis [176], decrements in performance might be traced back to a general decline in
basic attentional processes, such as arousal, required to perform in a WM task. Tucker et al., for instance,
disentangled executive from non-executive WM components and showed that specifically the latter
were affected by extended wakefulness [178].
In parallel, sleep loss-related declines in WM have been proposed to be due to their particular
dependence on activity in the PFC. Harrisons and Horne [124] suggested that the PFC, continuously
challenged during wakefulness, is specifically sensitive for the effects of SD. This so-called
neuropsychological hypothesis [176] is underlined by a predominance of delta and theta power
EEG in frontal areas during recovery sleep from SD [43]. Additionally, in animals, the wake-dependent
increase in adenosine has been specifically observed in the basal forebrain, located frontally [57].
Furthermore, the up-regulation of human A1-receptors after 24 h SD has been reported to be most
pronounced in the orbito-frontal cortex [121]. In further support for the neuropsychological hypothesis,
Drummond et al. showed that performance in the inhibition of prepotent responses, a specific executive
aspect of WM, was impaired by SD, while the general ability to correctly respond to frequent trials
was not affected [179]. A similar specific effect of high sleep pressure has been reported regarding the
executive WM component of switching [180].
However, several studies report stable levels of WM performance, specifically for higher-order
executive functions, over the course of SD. Roughly a decade ago, it was even considered as
“prevailing view in SD research ( . . . ) that high-level complex skills are relatively unaffected by
SD( . . . )” [124], p. 236. This view was based on the idea that higher-order cognitive tasks generate a
kind of motivation or interest, which leads to compensatory effort to perform well, even under high
sleep pressure [124].
Accordingly, neuroimaging studies investigating the impact of sleep loss on WM-related brain
activity revealed a complex pattern of increases and decreases in several brain regions [181]. Compared
to baseline, activity decreases have been observed after sleep loss in fronto-parietal brain areas and
associated with declines in several aspects of WM performance [182–187]. The maintenance of stable
WM performance in sleep deprived states has been traced back to compensatory increases at the brain
activity level in frontal, anterior cingulate and thalamic areas [182,184,186,188]. One factor modulating
compensatory increases has been proposed to be task complexity: Better performance after SD was
observed in the more complex tasks and proposed to be related to increases in prefrontal and thalamic
activity [182]. Furthermore, it has been observed that individuals highly differ in compensatory
brain activity patterns. These variations presumably underlie stable inter-individual differences in
vulnerability to sleep loss at the behavioral level [189].
Do Adenosinergic Mechanisms Play a Role in Sleep-Pressure-Related WM Deficits?
As briefly mentioned above, the blockade of adenosinergic receptors by caffeine has previously
not been associated with enhanced WM performance when studied during a normal waking
day [21,174,175]. However, caffeine exerted a positive effect on performance in several executive
functions when administered after 64 h of SD [190]. Additionally, caffeine ameliorated wake-dependent
decreases in short-term memory performance only after a certain sleep pressure level was reached [21].
Thus, a blockade of adenosinergic receptors appears to be beneficial for WM under conditions of
sleep-pressure-related performance troughs.
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Furthermore, there are indications that genetic variations in the adenosinergic system impact on
WM performance according to sleep pressure levels. Under conditions of sleep restriction, knockout
of neuronal adenosine A1 receptors was associated with a reduction of WM performance compared
to performance of wild phenotype animals [191]. Furthermore, in humans, WM performance
was differentially regulated according to the ADA-polymorphism rs73598374. We observed that
sleep-pressure-dependent performance modulations, specifically in executive aspects of WM, were
evident in G/A- but not in G/G-allele carriers [12]. Moreover, compared to G/G-allele carriers,
G/A-allele carriers benefited more in WM performance from REM sleep duration in the early morning
hours [49].
Together, these studies suggest that a behavioral variation following a dampening of adenosinergic
effects, either due to receptor blockade, receptor expression, or differential metabolization, might be
more likely observed under conditions of a high adenosinergic tone and a concomitant high sleep
pressure level.
3.4. Circadian Modulation
Finally, it is important to consider that the impact of sleep loss on WM performance is dependent
on circadian phase. The present evidence indicates that partial aspects of WM performance deteriorate
at night, such as processing speed, focused attention and short-term memory functions [16–21].
However, higher executive functions remain rather stable during nighttime, as, for instance,
inhibition [22] or planning performance [23]. Correspondingly, Monk reported a negative correlation
of the circadian variation in cortisol and WM speed, while WM accuracy was not significantly
associated [192].
Intriguingly, under conditions of sleep loss and concomitant high sleep pressure levels,
higher-order executive functions have been observed to decrease at night. This pattern is not simply
due to a rise in sleep pressure, as performance stabilized or increased again when wakefulness was
extended to the following day [22,23]. Thus, the impact of sleep pressure is enhanced during the night,
but counteracted during the day. This interaction of sleep homeostatic and circadian mechanisms was
also generally shown in tasks assessing more basic functions, but not in a consistent manner [16–21].
These inconsistencies are most likely due to study designs, in which wakefulness was restricted to less
than 16 h. Under these conditions, sleep pressure levels might not be high enough to exert a clear-cut
influence at night [17,20,21].
Recently, we assessed cerebral correlates of higher-order WM performance during both a 40-h
SD protocol and a 40-h NP. Similar to Chee et al. (2006) [183], the data revealed that performance and
underlying frontal BOLD activity decreased specifically under SD from day to nighttime (Figure 5).
When wakefulness was extended to the evening of the next day, we observed performance increases
from nighttime to the second day and no significant concomitant changes in frontal BOLD activity
(Figure 5). The latter indicates stabilization at the cerebral activity level despite of rising sleep pressure
levels, which might be either due to a floor effect in BOLD activity or to the switch in circadian
phase from night to daytime. Interestingly, during the second day, a superior frontal area (x = 20;
y = ´2; z = 56), underlying successful WM performance, was functionally connected to a region in the
hypothalamus. Together, these data underline the interaction of circadian and homeostatic mechanisms
at the BOLD activity level. They indicate that high sleep pressure, specifically at night, is detrimental
for frontal brain activity, underlying successful WM performance. As soon as daytime is reached,
circadian alerting signals of hypothalamic origin might support WM underlying brain mechanisms
such that brain activity does not further decline, despite rising sleep pressure.
In sum, the emerging picture suggests that the more basic processes required for WM decrease
during nighttime. These nighttime troughs are pronounced under high sleep pressure, and can only
be observed under these adverse conditions in higher-order executive functions. Under low sleep
pressure, complex tasks might trigger motivational resources that help to overcome circadian nighttime
troughs in cognitive performance [124]. Alternatively, compensatory brain mechanisms might operate
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in a more successful manner when the implicated network is more widespread, as typical for more
complex cognitive processes [189]. Such compensatory mechanisms might contribute to a vulnerability
to sleep loss at night.Biology 2016, 5, 11 15 of 24 
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imgages. * p < 0.01; p-value at peak-level after family-wise error correction (FWE), applied on a mask 
encompassing brain regions typically underlying n-back performance according to [146]. We did not 
find any other significant BOLD activity changes. Coordinates (x, y, z) are expressed in mm in the 
Montreal Neurological Institute (MNI) space, (unpublished data) [193]. 
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Figure 5. BOLD activity underlying successful WM during total SD. BOLD activity was assessed during
hit targets in a 3-back task after 13 h (Day 1), 21 h (Night) and 37 h (Day 2) of continuous wakefulness
in constant posture and lightning conditions. From a circadian perspective, these time windows
encompass maximal promotion of wakefulness (Day 1, Day 2) and sleep (Night). Left: Significant
changes in estimated BOLD responses in frontal brain regions. Right: Location of significant changes in
estimated BOLD response, highlighted by red rectangles on mean structural imgages. * p < 0.01; p-value
at peak-level after family-wise error correction (FWE), applied on a mask encompassing brain regions
typically underlying n-back performance according to [146]. We did not find any other significant
BOLD activity changes. Coordinates (x, y, z) are expressed in mm in the Montreal Neurological Institute
(MNI) space, (unpublished data) [193].
4. Conclusions
The empirical evidence, summarized above, leaves no doubt that sleep-homeostatic and circadian
mechanisms do interact. Differential methodological approaches not only revealed possible interfaces
of sleep-homoeostatic processes and the circadian timing system, but also indicate that the influence of
sleep pressure is differentially modulated according to circadian phase. Given the possibility of an
entrainment to cyclic environmental changes, such an interaction appears to be adaptive: Periods of
sleep, necessary for survival [194], are more intensively favored during times when the environmental
light-dark situation favors rest. The other way around, the impact of homeostatic sleep propensity is
counteracted as long as environmental light conditions allow optimal wakefulness (e.g., successful
foraging during daylight in diurnal species).
At present, studies indicate that there is a role for adenosine in sleep homeostasis and in
the interaction with circadian mechanisms. However, the particular adenosinergic contributions
to the effects of time spent awake on several levels of physiology and behavior remains to be
specified. Future research might focus not only on interactions with other sleep factors, but also
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on inter-individual differences due to ageing and genetic predispositions. A further open question
concerns differences between acute and long-term changes in adenosinergic mechanisms. So far, in
humans, the sparse empirical evidence lets us assume adaptations to variations in the adenosinergic
systems over long terms [195]. However, the temporal dynamics of this process and the interaction
with inter-individual differences are unknown, as, for instance, differences in adenosine receptors and
caffeine sensitivity [196].
Research targeting these questions might also be applied to the effects of adenosine on
cognitive performance and underlying cerebral correlates. The studies summarized above suggest a
beneficial effect of adenosinergic blockades on WM performance, when assessed under conditions of
sleep-pressure-related performance declines. Cerebral correlates of adenosinergic benefits under high
sleep pressure remain to be elucidated, controlled for a confounding influence of adenosine on BOLD
activity patterns [197]. Similarly, the positive effects of circadian wake-promotion after a night of sleep
loss have to be studied in more detail, not only in the domain of WM, but also in other cognitive
domains. Finally, sophisticated analyses on neuroanatomic and neuropharmacological conditions of
circadian wake-promoting activity at the individual level might have implications for the frequently
encountered performance errors during night and shiftwork.
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